It has been previously demonstrated that changes in the levels of apolipoprotein C-II (apoC-II) and apolipoprotein C-III (apoC-III) may be involved in the mechanisms underlying dyslipidemia in insulin resistance conditions. This evidence concerns the gene APOC2 and Insulin resistance.